W. H. Wilson Tang, MD

363 posts

W. H. Wilson Tang, MD banner
W. H. Wilson Tang, MD

W. H. Wilson Tang, MD

@WilsonTangMD

Opinions are my own.

Cleveland, OH Katılım Nisan 2017
7 Takip Edilen1.5K Takipçiler
W. H. Wilson Tang, MD retweetledi
Elon Musk
Elon Musk@elonmusk·
xAI was reorganized a few days ago to improve speed of execution. As a company grows, especially as quickly as xAI, the structure must evolve just like any living organism. This unfortunately required parting ways with some people. We wish them well in future endeavors. We are hiring aggressively. Join xAI if the idea of mass drivers on the Moon appeals to you.
xAI@xai

Since xAI was formed just 30 months ago, the small and talented team has made remarkable progress. The future has never looked more exciting!

English
9K
9K
55K
20.5M
W. H. Wilson Tang, MD retweetledi
Cardiovascular Research Foundation
Three Days. Endless Innovation. 🚀 Dive into pioneering data and transformative innovations in #heartfailure treatment with the program guide: your ultimate resource for navigating #THT2026! ow.ly/nc2550XC4UN Not registered yet? Secure your spot and save when you register before Dec. 17.⌛ ow.ly/UKzj50XC4UQ #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @TCTMD
English
0
3
10
776
W. H. Wilson Tang, MD retweetledi
JACC Journals
JACC Journals@JACCJournals·
From the CABANA trial: Patients with #HFpEF benefited even more from #Afib ablation regarding: 🔸Death/CV 🏥 🔸AF recurrence Despite the greater benefit for HFpEF pts, their risk of recurrence remained ⬆️ than in those w/out HFpEF 📎: jacc.org/doi/10.1016/j.… #JACCHF
JACC Journals tweet media
English
1
28
76
8.9K
W. H. Wilson Tang, MD retweetledi
Cardiovascular Research Foundation
🚨 Final Call: Secure Your Discounted Room by January 22! Stay at the Omni Boston Hotel at the Seaport, the official #THT2025 venue. Rooms are limited — don’t wait! ✅ Registered attendees, use the reservation link in your confirmation email to secure your spot (subject to availability). Not registered yet? Register now to lock in your stay! tht2025.crfconferences.com/register #heartfailure #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @navinkapur4 @dranulala @MartyBLeon @LindenfeldJoann @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference
English
0
5
5
1.4K
W. H. Wilson Tang, MD
W. H. Wilson Tang, MD@WilsonTangMD·
@CardioNerdsJC This is in contrast with many HF trials that have resulted in neutral results, in part because many factors (cardiac or extra-cardiac) may affect pVO2 in pts with HF.
English
0
0
2
41
W. H. Wilson Tang, MD
W. H. Wilson Tang, MD@WilsonTangMD·
@CardioNerdsJC This is one scenario that change in pVO2 is a good choice for primary endpoint because the key determinant of pVO2 in oHCM is the obstructive physiology that is being relieved by the intervention.
English
1
2
8
431
CardioNerds Journal Club
CardioNerds Journal Club@CardioNerdsJC·
Now what we all have been waiting for, the key finding: ⭐️ Mean change from baseline to week 24 in peak VO2 uptake, for aficamten vs. placebo, was: 1.8 vs. 0.0 mL/kg/min (p < 0.0001)
CardioNerds Journal Club tweet media
English
2
5
9
2.5K
Christopher Kramer MD
Christopher Kramer MD@ChrisKramerMD·
@CardioNerdsJC Fewer sarc+ patients than the average HCM clinic (35% or so) but obstruction is more common in Sarc- pts
English
1
2
5
1.1K
CardioNerds Journal Club
CardioNerds Journal Club@CardioNerdsJC·
Is this a representative HCM population? Specially looking at: 🌎 79% White patient representation 🧬17.5% with pathogenic sarcomeric variant 💊Prevalence of BB, CCB, disopyramide use 🫀NYHA Class ratio #CardsJC
CardioNerds Journal Club tweet media
English
5
3
8
1.6K
Jeroen Dauw
Jeroen Dauw@JeroenDauw·
Last Wednesday I successfully defended my PhD ‘Unravelling congestion in heart failure: mechanisms, diagnosis and treatment’. Special thanks to my promotor @WilfriedMullens, my family, the exquisite members of the jury and all people who helped me throughout my journey!
Jeroen Dauw tweet media
English
15
1
70
3K
W. H. Wilson Tang, MD retweetledi
Eric Topol
Eric Topol@EricTopol·
Niacin, the B vitamin that was previously used to improve lipid profile and reduce the risk of heart disease, promotes arterial inflammation and cardiovascular risk through its metabolites nature.com/articles/s4159… @NatureMedicine
Eric Topol tweet media
English
0
400
1.2K
446.9K
W. H. Wilson Tang, MD retweetledi
JACC Journals
JACC Journals@JACCJournals·
The new #JACCHF issue is now out! Hemodynamic gain index and peak rate pressure product can identify patients w/ #HFrEF at risk of poor clinical outcomes. This allows prognostication of #HeartFailure even when CPET is not available. bit.ly/49p3hjk #CHF @WilsonTangMD
JACC Journals tweet media
English
2
9
37
9.6K
W. H. Wilson Tang, MD retweetledi
Myocarditis Fndn
Myocarditis Fndn@myocarditisfndn·
The MF is thrilled to announce one of the 2023 Fellowship Grant recipients, Dr. Simon Vanhentenrijk, MD, Pharm D, of the Cleveland Clinic! Read about his work below. myocarditisfoundation.org/the-myocarditi…
English
0
1
5
962
W. H. Wilson Tang, MD retweetledi
American College of Cardiology
Q: Is intravenous iron beneficial for patients with #heartfailure and iron deficiency? A: In patients with HF and iron deficiency, treatment with IV iron can reduce CV deaths and HF hospitalizations. bit.ly/4aL4MKs #JACCHF
American College of Cardiology tweet media
English
0
36
100
13.4K